Article Text
PDF
Other content recommended for you
- Treatment of dementia
- Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
- Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews
- Discontinuation of cholinesterase inhibitor treatment in institutionalised patients with advanced dementia
- Cognitive symptoms of Alzheimer’s disease: clinical management and prevention
- Cholinesterase inhibitors and memantine for symptomatic treatment of dementia
- Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis
- The China Alzheimer Report 2022
- Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer’s disease
- Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry